Biden’s FDA put out guidance to health care providers that lists “race or ethnicity” as a risk factor, which critics say essentially means people with certain immutable characteristics are able to qualify quicker for coronavirus treatments like monoclonal antibodies and oral antiviral pharmaceuticals.
en un fact sheet issued for health care providers by the Food and Drug Administration, the federal agency approved emergency use authorizations of sotrovimab – a monoclonal antibody proven to be effective against the omicron variant – only to patients considered “high risk.”
A person’s race or ethnicity was subsequently listed as a factor that has the potential to “place individual patients at high risk for progression to severe COVID-19,” agregando que el “authorization of sotrovimab under the EUA is not limited to” other factors outlined by the agency.
“I grew up [y] have been around long enough to remember going to Tennessee when I was 6 years old and seeing the White and Colored drinking fountains,” Carson told “La historia” when asked about the new federal policy guidance.
“[yo recuerdo] seeing the dogs and the hoses being used on people [y] suffering all kinds of insults on the base of your race.”